Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with advanced epithelial ovarian cancer. A phase II trial of sequential doublets. (GO-FIRST)
2004 ◽
Vol 22
(14_suppl)
◽
pp. 5034-5034